NEW YORK, Sept. 04, 2019 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics ...

NEW YORK, Jan. 02, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative ...

BUFFALO, N.Y. — Scientists at the University at Buffalo Research Institute on Addictions (RIA) are taking part in a National Institute on Drug Abuse (NIDA) Center of Excellence study on the genetics ...

A study released by the Centers of Excellence finds that job opportunities in the solar industry are expected to increase by up to 40% in the next three years. The "Solar Industry & Occupations: ...

Anavex Life Sciences Corp. AVXL reported mixed results from the mid to late-stage EXCELLENCE study evaluating the clinical efficacy, safety and tolerability of its investigational candidate, 30 mg ...